The nation’s largest network of ketamine health clinics is the first virtual programming of its kind to help patients’ loved ones prepare for life after experiencing Ketamine infusion.
VANCOUVER, BC, November 18, 2021 / PRNewswire / – Delic Holdings Corp: (“Delic” or “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), the leader in the treatment of new drugs ժամանակակից in the modern world, presented today Family support և education program at: Ketamine Health Centers (KWC)The largest network of ketamine treatment centers in the United States at KWC was recently acquired by Delic, with 10 ketamine infusion treatment clinics in eight states that have so far delivered more than 60,000 treatments nationwide. Arizona, Colorado, Florida:, Illinois, Minnesota:, Njada, Texas: և: Washington:.
KWC Family Support և Education is a unique, free program designed specifically by medical professionals to help families, significant others and loved ones provide significant support to patients who have opted for ketamine infusion treatment. While ketamine represents a new class of drugs that have revolutionized therapies for depression, its rapid effects and benefits can rapidly change the dynamics of family and relationships. KWC Virtual Family Support և Education sessions will address relevant topics, including what friends and family can expect from the process, roles they can take to support the patient during treatment, and how they can prepare for rapid positive changes in the lives of their loved ones. : .
He will chair the session every hour Mr. Nicholson, CEO of KWC գլխավոր Chief Operating Officer of Delic, with over 20 years of clinical and healthcare management experience. In addition to providing patients’ families with resources and practical guidance, the program also allows participants to connect in a safe, supportive, community-centered environment.
“After delivering more than 60,000 treatments across the country, our team recognized the clear need of patients’ loved ones to better understand how to support the full impact of ketamine infusion therapy and how they can support treatment,” Nicholson said. “The long-term success of these treatments often depends on the quality of the patients’ environment when they leave our clinic.
“Delic is proud to offer this free, vital service to help our ailing communities in the United States get the support they need at this difficult time in their lives,” he said. Matt Stang, Co-founder and CEO of Delic. “Since 2015, KWC has been a leader in providing personalized, effective, affordable mental health care, such as major depression, anxiety, PTSD, and is an example of doing the right thing. We are confident that Kane’s team will guide these families during this journey with the same care and attention they provide to all their patients through the Family Support և Education program. ”
The KWC National Network of Clinics adds to the existing portfolio of two Delic clinics operated by Ketamine Infusion Centers LLC (KIC). California: և: Arizona, strengthening its position as a leading և largest provider of health in the country. Delic expects to open 15 additional clinics across the country over the next 18 months, further expanding access to millions of people who can access new medicines, treatments for a variety of mental health conditions, and increase their position as a hub for education and media. և Cultural conversations about these new medicines և Treatment. With its recent successful personal deployment of 7mm CAD, Delic is actively looking for new locations in cities with a growing patient base.
About Ketamine Health Centers
Ketamine Health Centers (KWC) Is the largest provider of ketone therapy United States: With 10 clinics serving communities in eight states. Since 2011, KWC has been a reliable leader in introducing IV ketamine therapy into primary care. KWC has provided more than 60,000 treatments to clinically competent patients, from young adults to the elderly, in addition to developing specialized programs for veterans and first responders. The KWC team, including a core team of physicians, psychologists, clinicians, and leaders, is dedicated to value-based, personalized, clinically controlled ketamine infusion care treatment for people suffering from depression, anxiety, PTSD, OCD, and chronic pain. . KWC’s large-scale business և treatment model is designed for further rapid expansion, as well as breakthrough innovations in effective treatment և services.
About Delic Corp.
Delicate is a leader in the modern world նոր in the field of new medicines և treatments, improving the availability of health benefits throughout the country, transforming the talk of psychotropic drugs. The company owns և operates an umbrella for related businesses, including the largest network of psychiatric health clinics in the country, including Ketamine Infusion Centers և Ketamine Health Centers; The only Canadian-licensed healthcare organization dedicated solely to the research and development of psilocybin evaporation technology. Delic Labs:; Primary psychiatric health event: Meet Delic; և trusted media և e-commerce platforms Reality Sandwich և Delic Radio. Delic is supported by a team of industry և cannabis veterans և a diverse network whose mission is education, research, high quality products և to provide effective treatment options to the masses.
The Canadian Stock Exchange has neither endorsed nor denied the contents of this news: is not responsible for the adequacy or accuracy of this issue.
The release of this news is not an offer to sell securities or an offer to buy. United States:. The securities have not been registered or will not be registered United States: The Securities Act of 1933, as amended (U.S. Securities Act) or a government securities law that cannot be offered or sold United States: Except as registered under the US Securities Act, or under such securities law.
Outlook և Announcements
This press release contains some “prospective information” within the meaning of applicable Canadian securities legislation; Securities Litigation Reform Act 1995. Such prospective information և future statements do not represent historical facts or information or the current situation, but rather represent only the Company’s beliefs about future events, plans or goals, many. which, by their very nature, are indeterminate և out of Delich’s control. In general, such prospective information or forward-looking statements can be identified using forward-looking terminology such as “plans”, “expected” or “not expected”, “expected”, “budget”, “planned”, “estimates” , “Predictions”, “predicts”, “expects” or “does not expect”, or “believes”, or variations of such words և may contain: Statements that certain actions, events or results “can”, “can”, “can”, “can” or “will be taken”, “will continue”, “will be performed” or “will be achieved”. Prospective information with this content և may include, but are not limited to, future statements; Possible benefits of the transaction. Continued growth in health ոլորտում in the field of health (և, in particular, in relation to psychotropic drugs) is expected; Delic’s ability to successfully achieve business goals և expectations for other economic, business և and / or competitive factors.
By disclosing such information and statements in a similar manner, Delic warns the reader that such information and statements are subject to known և unknown risks, uncertainties և other factors that may result in actual results, activity level, performance or achievement. Delic differs significantly from such information և in statements made or assumed. Such risks և other factors may include, but are not limited to: Risks և Uncertainties related to the non-closing of the Transaction, as planned or in general or under the terms of the merger agreement. Wrong estimate of transaction value և potential benefits. Direct և material adverse effects of COVID-19 epidemic. Inability to obtain future funding on appropriate terms. not receiving the required regulatory և other approvals. Risks inherent in the field of psychiatric treatment. Changes in applicable laws and regulations. ելը non-compliance with applicable laws և regulations.
In addition, Delik has made some assumptions about the prospective information և prospective statements contained in this press release. These assumptions include, but are not limited to: Ability to complete the transaction; Ability of the parties to obtain the necessary regulatory, corporate և third party approvals ժամանակ on time under the proposed terms, other conditions for the transaction. The possible impact of the announcement or termination of the transaction on the relationship, including with regulators, employees, suppliers, customers և competitors. Changes in general economic, business and political conditions, including changes in financial markets. changes in applicable legislation; Compliance with large-scale government regulations. շ Deviation of transaction management time
If one or more of these risks, uncertainties, or other factors occur, or if the assumptions underlying future information or statements are incorrect, the actual results may differ significantly from those described here as intended, planned, expected, estimated, estimated. or expected.
Although Delic believes that the assumptions and factors used in the preparation և the expectations contained therein, the prospective information և the statements are reasonable, such information և statements չպետք should not be misplaced, there can be no guarantee or warranty. Keep in mind that such prospective information և statements will be accurate, as the actual results ագա future events may differ significantly from those expected in such information և statements. Prospective information contained in this press release և Prospective announcements made as of the date of this press release և Delic is not obligated to update any future information և / or forward-looking statements. contained or listed herein, except in accordance with applicable securities laws. All subsequent written և prospective information և announcements attributed to Delic or acting on its behalf are fully qualified by this notice.
SOURCE Delic Holdings Inc.